Law360, New York (September 11, 2009) -- A federal judge has dismissed a declaratory judgment suit filed by Teva Pharmaceuticals Inc. and its Gate Pharmaceuticals division seeking a determination that they did not infringe four patents covering Eisai Co. Ltd.'s blockbuster Alzheimer's drug Aricept.
In a ruling handed down Sept. 10 in the U.S. District Court for the District of New Jersey, Judge Garrett E. Brown Jr. found that Teva did not risk a...
